Department of Urology, SUNY Downstate College of Medicine, Brooklyn, NY, USA.
Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
J Pediatr Urol. 2022 Aug;18(4):463.e1-463.e8. doi: 10.1016/j.jpurol.2022.05.022. Epub 2022 Jun 2.
The comparative effectiveness of high-power laser technology for kidney stone surgery in pediatric patients is poorly understood. We compared outcomes for the 120 W Holmium:yttrium-aluminum-garnet (Ho:YAG) laser with MOSES technology to 30 W Ho:YAG laser for pediatric patients undergoing ureteroscopy with laser lithotripsy for kidney and ureteral stones.
We evaluated the outcomes of the new MOSES laser technology as compared to low-power Ho:YAG lasers commonly used for kidney stone treatment in the pediatric population.
We performed a retrospective cohort study of 131 consecutive patients aged 1-18 years who underwent ureteroscopy and laser lithotripsy for renal and ureteric calculi at a large freestanding children's hospital between 2013 and 2020. The primary outcome was the efficiency quotient, which incorporates stone clearance, auxiliary procedures, and retreatment rates. Outcomes were compared between groups using Chi-square or Fisher's exact tests and multivariable regression. A sensitivity analysis was performed extending the age limit to ≤21 years.
Outcomes are summarized in the table below. Median age of the cohort was 14 years with 53% of patients being female. MOSES laser had a higher efficiency quotient and was associated with a lower odds of post-operative emergency department visits (OR 0.2, 95% CI 0.0-1.0; p = 0.047). Operative time was similar. In the sensitivity analysis of patients ≤21 years, the statistical significance with fewer emergency department visits was lost and the efficiency quotient was lower.
Our results show that stone clearance is similar between the 120 W MOSES and 30 W Ho:YAG lasers. However, there are indications that high-power laser lithotripsy is more efficient due to fewer auxiliary procedures and a reduction in retreatment. In addition, higher power lasers were associated with fewer emergency department visits. The benefits appear to be greater among children ≤18 years. These exploratory findings are important for pediatric patients due to the requirement for general anesthesia for each procedure and their associated impact on children and their caregivers.
High-power laser lithotripsy may be more efficient than lower power laser lithotripsy, which is driven by the fewer auxiliary procedures and reduction in retreatment particularly among youth ≤18 years old.
高能激光技术治疗小儿肾结石手术的疗效尚不清楚。我们比较了 120W 钬:掺钕石榴石(Ho:YAG)激光与 MOSES 技术和 30W Ho:YAG 激光在接受输尿管镜检查和激光碎石治疗肾结石和输尿管结石的小儿患者中的疗效。
我们评估了新的 MOSES 激光技术的结果,与小儿人群中常用的低功率 Ho:YAG 激光治疗肾结石的结果进行了比较。
我们对 2013 年至 2020 年间在一家大型独立儿童医院接受输尿管镜检查和激光碎石治疗肾结石和输尿管结石的 131 例年龄 1-18 岁的连续患者进行了回顾性队列研究。主要结局指标是效率商,包括结石清除率、辅助手术率和再治疗率。使用卡方检验或 Fisher 精确检验和多变量回归比较组间的结果。灵敏度分析将年龄限制延长至≤21 岁。
总结如下表所示。队列的中位年龄为 14 岁,其中 53%的患者为女性。MOSES 激光的效率商更高,与术后急诊就诊的几率较低相关(OR 0.2,95%CI 0.0-1.0;p=0.047)。手术时间相似。在≤21 岁患者的灵敏度分析中,急诊就诊次数减少的统计学意义丧失,效率商降低。
我们的结果表明,120W MOSES 和 30W Ho:YAG 激光之间的结石清除率相似。然而,有迹象表明,由于辅助手术减少和再治疗减少,高能激光碎石术更有效。此外,高功率激光与急诊就诊次数减少相关。这些好处在≤18 岁的儿童中更为明显。这些探索性发现对于小儿患者很重要,因为每次手术都需要全身麻醉,这会对儿童及其照顾者产生影响。
高能激光碎石术可能比低功率激光碎石术更有效,其效率的提高主要是由于辅助手术减少和再治疗减少,尤其是在≤18 岁的青少年中。